ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 23 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,000 | +166.7% | 6,323 | +139.3% | 0.00% | – |
| Q2 2023 | $27,000 | +170.0% | 2,642 | +99.1% | 0.00% | – |
| Q1 2023 | $10,000 | -56.5% | 1,327 | -57.9% | 0.00% | – |
| Q4 2022 | $23,000 | +2200.0% | 3,155 | +1560.5% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 190 | +115.9% | 0.00% | – |
| Q2 2022 | $1,000 | -83.3% | 88 | -87.7% | 0.00% | – |
| Q1 2022 | $6,000 | -83.3% | 713 | -72.7% | 0.00% | – |
| Q4 2021 | $36,000 | +200.0% | 2,612 | +120.8% | 0.00% | – |
| Q3 2021 | $12,000 | +71.4% | 1,183 | +48.8% | 0.00% | – |
| Q2 2021 | $7,000 | – | 795 | +9837.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 8 | -92.2% | 0.00% | – |
| Q3 2020 | $1,000 | -98.8% | 103 | -98.8% | 0.00% | – |
| Q2 2020 | $81,000 | +440.0% | 8,353 | +56.1% | 0.00% | – |
| Q1 2020 | $15,000 | +1400.0% | 5,351 | +2031.9% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 251 | -29.7% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 357 | +42.8% | 0.00% | – |
| Q2 2019 | $1,000 | -80.0% | 250 | -66.7% | 0.00% | – |
| Q1 2019 | $5,000 | +66.7% | 750 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 750 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | -16.7% | 750 | 0.0% | 0.00% | – |
| Q2 2018 | $6,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -25.0% | 750 | 0.0% | 0.00% | – |
| Q4 2017 | $8,000 | +166.7% | 750 | +198.8% | 0.00% | – |
| Q3 2017 | $3,000 | – | 251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 3,056,420 | $22,006,000 | 19.85% |
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $48,300,000 | 17.51% |
| GREAT POINT PARTNERS LLC | 3,448,521 | $24,829,000 | 5.98% |
| Omega Fund Management, LLC | 2,029,580 | $14,613,000 | 5.35% |
| Paradigm Biocapital Advisors LP | 2,214,722 | $15,946,000 | 2.13% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $21,497,000 | 1.66% |
| COMMODORE CAPITAL LP | 1,325,000 | $9,540,000 | 1.53% |
| Octagon Capital Advisors LP | 1,225,000 | $8,820,000 | 1.52% |
| RA Capital Management | 4,356,632 | $31,368,000 | 0.67% |
| TCG Crossover Management, LLC | 254,569 | $1,833,000 | 0.55% |